
Lauren M Petrick, PhD
About Me
Lauren Petrick, PhD, is a Professor of Environmental Medicine and Head of Untargeted Metabolomics at the Senator Frank R. Lautenberg Environmental Health Sciences Laboratory at the Icahn School of Medicine at Mount Sinai. Dr. Petrick is an analytical chemist with advanced training in metabolomics and exposomics. Her research focuses on developing untargeted exposomics methodologies for environmental health studies, leveraging high-resolution mass spectrometry (HRMS) and advanced biostatistics and bioinformatics.
In addition to traditional analyses of urine, plasma, and serum in large cohort studies, Dr. Petrick’s current work emphasizes minimally invasive sampling approaches—such as dried blood spots, capillary blood microsamplers, and wearable wristbands—that can be collected at home and mailed in. These approaches enable accelerated recruitment and retention in large-scale clinical and epidemiological studies, particularly among sensitive or hard-to-reach populations.
By capturing environmental exposures (e.g., pesticides, PFAS, personal care products, tobacco) and biological response markers (e.g., fatty acids, bile acids, lipid mediators) in a single assay, her untargeted workflows enable early disease detection, targeted prevention strategies, and personalized health monitoring.
Learn more about Dr. Petrick's Lab: www.petrickexposomelab.com
Language
English
Position
PROFESSOR | Environmental Medicine
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Genetics and Genomic Sciences [GGS]
Education
BSc, Cornell University
MSc, University of California at Davis
PhD, Technion-Israel Institute of Technology, Haifa, Israel
Postdoctoral fellow, Technion-Israel Institute of Technology, Haifa, Israel
Postdoctoral fellow, University of California at Berkeley
Awards
Environment and Health Fund (EHF) postdoctoral fellowship (2014-2016)
The Israeli Society of Ecology and Environmental Science: Outstanding Research Award Winner in Air Pollution (2010)
Israel Ministry of Science Scholarship for the Advancement of Women in Science (2009-2010)
Technion Fellowship for Graduate Studies (2006-2011)
Lady Davis Fellowship (2006-2007)
California Association of Criminalists A. Reed and Virginia McLaughlin Endowment Research Award (2004-2005)
Publications
Selected Publications
- Phthalates measured at birth and risk of testicular cancer in adolescents and young adults. Catherine Metayer, Chris Gennings, Libby M. Morimoto, Shachi Mistry, Katherine A. McGlynn, Georgia Dolios, Haibin Guan, Carina C. Gonzaga, Syam S. Andra, Lauren Petrick. JNCI Cancer Spectrum
- Nontargeted screening identifies mixtures of environmental pollutants that are associated with perturbations to amino acid and fatty acid metabolic pathways during early pregnancy. Adam F. Pedersen, Lauren M. Petrick, Katherine Roth, Zhao Yang, Alexandra R. Sitarik, Amith Maroli, Georgia Dolios, Courtney Carignan, Jaclyn M. Goodrich, Jean M. Kerver, Michael Petriello. Environment international
- Postpartum metabolomics profile predicts 8-years postdelivery women’s subclinical atherosclerosis measures. Katherine Svensson, Marco Sanchez-Guerra, Vishal Midya, Haibin Guan, Megan Niedzwiecki, Georgia Dolios, Citlalli Osorio-Yáñez, Luz M. Del Razo, Julio C. Ayllon-Vergara, Guadalupe Estrada-Gutierrez, Maria Luisa Pizano Zárate, Lauren Petrick, Martha M. Téllez-Rojo, Robert O. Wright, Elena Colicino. Scientific Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Petrick did not report having any of the following types of financial relationships with industry and other outside entities during 2025 and/or 2026: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.